An advanced blood test to diagnose heart attacks, currently in development by researchers at King’s College London, could be administered using a handheld device, according to research presented on June 5 at the British Cardiovascular Society conference in Manchester, U.K.

Erectile dysfunction (ED) is an independent predictor of cardiovascular disease (CVD), according to a research letter published June 11 in Circulation.

DALLAS, June 12, 2018 — The American Heart Association—the world’s leading voluntary organization dedicated to building healthier lives, free of cardiovascular diseases and stroke—announced today research grants totaling more than $28 million to the scientific teams that will create a new research network focused on understanding the causes of atrial fibrillation (AFib).

A new study published in PLOS Medicine suggests people prescribed a single-pill fixed-dose drug combination (FDC) to manage hypertension are more likely to be compliant with their medication and achieve better health outcomes than those taking separate pills.

The first coagulation monitoring device with built-in Bluetooth technology is expected to be commercially available this summer to warfarin patients in the United States, according to device-maker Roche Diagnostics.

Scientists are researching how to take stem cells from the patient’s blood to repair damage to the heart. A new therapy could reduce the need for operations, the U.K.’s Express newspaper reports, with researchers hoping the therapy could save lives while being cost effective. 

Patients who utilize a healthy lifestyle smartphone application may be able to slow arterial aging, according to results from the EVIDENT II trial presented at EuroHeartCare 2018 in Dublin.

Patients who progressed to having longer episodes of subclinical atrial fibrillation (SCAF) were more than four times as likely to be hospitalized for heart failure in a one-year span, according to a study published June 4 in the Journal of the American College of Cardiology.